Drug Shortage Report for INTEGRILIN

Last updated on 2019-08-19 History
Report ID 90224
Drug Identification Number 02240352
Brand name INTEGRILIN
Common or Proper name Eptifibatide Injection
Company Name MERCK CANADA INC
Active Ingredient(s) EPTIFIBATIDE
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 20MG/10ML VIAL
ATC code B01AC
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-08-12
Actual start date 2019-08-12
Estimated end date 2019-09-27
Actual end date
Shortage status Actual shortage
Updated date 2019-08-19
Company comments Limited quantity available
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2019-08-19 French Compare
v10 2019-08-19 English Compare
v9 2019-08-13 English Compare
v8 2019-08-12 French Compare
v7 2019-08-12 English Compare
v6 2019-08-12 French Compare
v5 2019-08-12 English Compare
v4 2019-08-09 French Compare
v3 2019-08-09 English Compare
v2 2019-07-30 French Compare
v1 2019-07-30 English Compare